Prostate Cancer

>

Latest News

In addition to tissue biopsy, a liquid biopsy test can be used to better identify patients who may benefit from niraparib and abiraterone acetate.
FDA Approves FoundationOne Liquid CDx for Niraparib Combo in BRCA+ mCRPC

July 1st 2024

In addition to tissue biopsy, a liquid biopsy test can be used to better identify patients who may benefit from niraparib and abiraterone acetate.

In a phase 1 trial, City of Hope’s CAR T-cell therapy showed minimal adverse effects and promising therapeutic activity for advanced prostate cancer.
CAR T-Cell Therapy Demonstrates Promising Results for mCRPC

June 27th 2024

Compared with cognitively-defined and hemigland contours, AI-assisted cancer contours delivered a greater balanced accuracy rate.
AI-Assisted Contours Exhibit High Accuracy in Evaluating Prostate Cancer

June 20th 2024

Cabazitaxel/Abiraterone Yields PFS Improvement in mCRPC
Cabazitaxel/Abiraterone Yields PFS Improvement in mCRPC

June 2nd 2024

Investigators aim to identify a clinically useful and safe dose of Illuminare-1 for future studies in surgical cancer care.
Novel Fluorophore May Reduce Complications in Prostate Cancer Surgery

May 23rd 2024

More News